# Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)

> **NCT01044758** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 96 (actual)

## Conditions studied

- Mild Cognitive Impairment (MCI)

## Interventions

- **DRUG:** Levetiracetam 62.5mg
- **DRUG:** Levetiracetam 125mg
- **DRUG:** Levetiracetam 250mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01044758
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2017-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01044758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01044758, "Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01044758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*